| http://www.w3.org/ns/prov#value | - of tumors, such as chemotherapeutic agents or irradiation therapy, as well as treatment withbiological response modifiers such as IL-2 and tumor suppressing cells such as lymphokine activated killer cells (LAK) and tumor-infiltrating lymphocytes (TIL cells); patients suffering from neoplasias generally, whether or not otherwise treatedincluding acute and chronic myelogenous leukemia, hairy cell le
|
